Sungmin Woo, MD, PhD
Oncologic Body Imaging; Multimodality Imaging of Genitourinary and Gynecologic Cancers; Prostate Cancer
Contact and Location
Memorial Sloan Kettering has locations throughout New York City, Long Island, New Jersey, and Westchester. These locations offer many services, including screening, chemotherapy, and medical testing.
MD, Seoul National University College of Medicine; PhD, Seoul National University College of Medicine
Radiology - Seoul National University Hospital
Oncologic Imaging - Memorial Sloan Kettering Cancer Center
I am a diagnostic radiologist with expertise in cancer imaging. My goal is to provide the best care for people with cancer, perform cutting-edge research to advance medicine, and to train the next generation of cancer experts.
My experience involves a combination of body and molecular imaging. I interpret CT, MRI, and ultrasound of the chest, abdomen, and pelvis, and investigate novel PET techniques. I have worked at top academic centers in both Korea and the United States.
As a member of the Urology and Gynecologic Oncology Disease Management Teams at MSK, I work closely with my colleagues in medical oncology, surgery, radiation oncology, and pathology. Our collective goal is to provide the best evidence-based care to those with cancer by combining our expertise. We strive to provide each and every person with care tailored to their specific needs and circumstances. It is a privilege for me to have the opportunity to contribute to and collaborate with world-class experts to accomplish this goal.
My research primarily focuses on imaging of prostate, bladder, and kidney cancers, as well as gynecologic cancers. The goal of my research is to assess how these cancers spread to other parts of the body, evaluate treatment response, and predict prognosis. I am especially interested in how advanced imaging such as cutting-edge MRI techniques and novel PET techniques can be used as biomarkers to improve how we diagnose and treat these cancers.
I am proud to be a part of MSK and to contribute to this prestigious institution’s reputation for excellence in patient care, research, and education.
We strive to provide each and every person with care tailored to their specific needs and circumstances.
Awards and Honors
- Roentgen Resident/Fellow Research Award, Radiological Society of North America Research and Education Foundation (2020)
Memorial Sloan Kettering's doctors and scientists are constantly developing new treatments for cancer. MSK is typically running hundreds of clinical trials at a given time.
You may be able to participate in a clinical trial even if you are new to MSK. Search our online directory to find trial information and see more about who can participate.
Research and Publications
Visit PubMed for a full listing of Dr. Woo’s journal articles. Pubmed is an online index of research papers and other articles from the US National Library of Medicine and the National Institutes of Health.
Doctors and faculty members often work with pharmaceutical, device, biotechnology, and life sciences companies, and other organizations outside of MSK, to find safe and effective cancer treatments, to improve patient care, and to educate the health care community.
MSK requires doctors and faculty members to report (“disclose”) the relationships and financial interests they have with external entities. As a commitment to transparency with our community, we make that information available to the public.
Sungmin Woo discloses the following relationships and financial interests:
No disclosures meeting criteria for time period
If you’re a patient at MSK and would like more information about your doctor’s external relationships, please talk with your doctor.
The information published here is for a specific annual disclosure period. There may be differences between information on this and other public sites as a result of different reporting periods and/or the various ways relationships and financial interests are categorized by organizations that publish such data.
This page and data include information for a specific MSK annual disclosure period (January 1, 2020 through disclosure submission in spring 2021). This data reflects interests that may or may not still exist. This data is updated annually.